Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

Bioorg Med Chem Lett. 2015 Jan 15;25(2):404-9. doi: 10.1016/j.bmcl.2014.09.070. Epub 2014 Oct 2.

Abstract

Regioselective synthesis, biological evaluation and 3D-molecular modeling for a series of novel diastereomeric 2-thioxo-5H-dispiro[imidazolidine-4,3-pyrrolidine-2,3-indole]-2,5(1H)-diones are described. The studied compounds have been tentatively identified as potent small molecule MDM2/p53 PPI inhibitors and can therefore be reasonably regarded as promising anticancer therapeutics.

Keywords: 3D molecular docking; Cell-based assay; Dispiro-indolinones; MDM2/p53; PPI inhibitors.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects*
  • Drug Design*
  • Humans
  • Models, Molecular
  • Molecular Dynamics Simulation
  • Molecular Structure
  • Neoplasms / drug therapy*
  • Neoplasms / pathology
  • Proto-Oncogene Proteins c-mdm2 / antagonists & inhibitors*
  • Small Molecule Libraries / chemical synthesis
  • Small Molecule Libraries / pharmacology
  • Structure-Activity Relationship
  • Tumor Cells, Cultured
  • Tumor Suppressor Protein p53 / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Small Molecule Libraries
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • MDM2 protein, human
  • Proto-Oncogene Proteins c-mdm2